Stay updated on APL-2 in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 in Neovascular AMD Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:56:08.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:32:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-30T04:28:36.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-23T01:25:14.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:01:14.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page has been updated to include new information about Neovascular Age-related Macular Degeneration and a new version revision, while significant details regarding the safety assessment study and its criteria have been removed.
    Difference
    31%
    Check dated 2025-04-16T16:43:26.000Z thumbnail image

Stay in the know with updates to APL-2 in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.